Author:
Alvarado-Navarro Dalila Marisol,Chávez-Estrada Yair Omar,Moncada-Saucedo Nidia Karina,Hernández-Navarro Ana Karen,Ake-Uc Martha Berenice,Gómez-De León Andrés,Salazar-Riojas Rosario
Reference9 articles.
1. Alexander T, Greco R, Snowden JA. Hematopoietic stem cell transplantation for autoimmune disease. Annu Rev Med. 2021; 72: 215-228.
2. Balassa K, Danby R, Rocha V. Haematopoietic stem cell transplants: principles and indications. Br J Hosp Med (Lond). 2019; 80 (1): 33-39.
3. Ataca Atilla P, Bakanay Ozturk SM, Demirer T. How to manage poor mobilizers for high dose chemotherapy and autologous stem cell transplantation? Transfus Apher Sci. 2017; 56 (2): 190-198.
4. Remberger M, Torlén J, Ringdén O, Engstrom M, Watz E, Uhlin M et al. Effect of total nucleated and CD34(+) cell dose on outcome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2015; 21 (5): 889-893.
5. Pura Krishnamurthy K, Sarathy V, Jayappa SB, Badarkhe GV, Kumar Ks R, Thianeshwaran S et al. Study of peripheral mononuclear cells and CD34 levels as a predictive marker for initiating apheresis in autologous stem cell transplant. Int J Hematol Oncol Stem Cell Res. 2021; 15 (3): 170-177.